Seagen Appoints David Epstein As New CEO

RTTNews | 1026 dias atrás
Seagen Appoints David Epstein As New CEO

(RTTNews) - Biotechnology company Seagen Inc. (SGEN) announced Thursday that its Board of Directors has appointed David Epstein as Chief Executive Officer (CEO) and a member of the Board of Directors.

Epstein brings more than 30 years of experience in the biopharmaceutical industry, including more than 25 years at Novartis where he built its oncology business unit from initiation to second largest in the world.

He then served as CEO of Novartis Pharmaceuticals, a division of Novartis AG, from 2010 to mid-2016. More recently, he was executive partner at Flagship Pioneering.

In addition, Seagen announced that Roger Dansey, M.D., who has served as Seagen's Chief Medical Officer (CMO) since 2018 and as Interim CEO since May 2022, has been appointed President, Research and Development.

In this new role, Dansey will continue to serve as CMO reporting to Epstein.

Etiquetas: SGEN
read more
Pfizer Closes $43 Bln All-cash Acquisition Of Seagen

Pfizer Closes $43 Bln All-cash Acquisition Of Seagen

Pfizer Inc. (PFE) announced Thursday the successful completion of its acquisition of biotechnology company Seagen Inc. (SGEN). Pfizer completed its acquisition of all outstanding common stock of Seagen for $229 in cash per share, for a total enterprise value of approximately $43 billion.
RTTNews | 627 dias atrás
Eurozone Manufacturing Growth At 38-Month High

Eurozone Manufacturing Growth At 38-Month High

The euro area manufacturing activity grew at the fastest pace in more than three years in August driven by a sharp rise in output and the renewed uptick in domestic demand, data published by S&P Global showed on Monday. The HCOB final manufacturing Purchasing Managers' Index improved to 50.7 in August from 49.8 in July. This was the first expansion in the currency bloc since June 2022. The flash
RTTNews | 37 minutos atrás
CAC 40 Up Slightly In Cautious Trade

CAC 40 Up Slightly In Cautious Trade

French stocks are up slightly in cautious trade on Monday as the focus remains on the upcoming confidence vote on French Prime Minister Francois Bayrou's government. Investors, digesting the latest batch of regional economic data, are also awaiting the crucial U.S. non-farm payroll data due later in the week.
RTTNews | 1 h 14 min atrás
DAX Advances; Pharma Stocks Among Notable Gainers

DAX Advances; Pharma Stocks Among Notable Gainers

The German market is modestly higher on Monday, as a U.S. appeals court ruling that many of Donald Trump's tariffs were illegal. Healthcare stocks are finding support after Danish pharma company Novo Nordisk's weight-loss drug Wegovy offered better heart-protective benefits than rival treatments from U.S.-based Eli Lilly.
RTTNews | 1 h 43 min atrás